About the GHSG

The Trial Coordination Center of the GHSG focuses on the conceptual design and preparation of clinical trials, documentation of patient data (courses of disease, etc.), data management and on the analysis and publication of study results.

So far over 15,000 patients have been included in the GHSG’s trials and have been treated according to the respective trial protocols. The trials dealing with the first-line treatment in Hodgkin lymphoma are currently in their sixth generation.

The GHSG is based on a close cooperation of physicians, such as oncologists, radiotherapists, nuclear-medical specialists, radiologists and pathologists, together with specialists for fundamental sciences, biomathematics and statistics, which has led to a continuous optimization of treatment regimens from trial generation to trial generation, so that 75-90% of Hodgkin lymphoma patients can be fully cured today.

The GHSG is financially supported by the Deutsche Krebshilfe (German Cancer Aid).